$301.90
-2.46 (-0.81%)
At Close: Jul 20, 2026
Has Bio-Rad Laboratories (BIO) Outpaced Other Medical Stocks This Year?
10:44am, Friday, 24'th Dec 2021
Here is how Bio-Rad Laboratories (BIO) and Fullgent Genetics (FLGT) have performed compared to their sector so far this year.
Global Cell Freezing Media Market Size [2021-2028] | Industry Share, Revenue, Competitive Landscape & Forecast
10:19am, Wednesday, 22'nd Dec 2021 Intrado Digital Media
Key Prominent Players Covered in the Cell Freezing Media Market are Thermo Fisher Scientific, Bio-Rad Laboratories, Abcam Plc, Merck KGaA, BioLifeSolutions Inc., HiMedia Laboratories, AMSBIO, BIOGENUIX MEDSYSTEM PVT.LTD. Key Prominent Players Covered in the Cell Freezing Media Market are Thermo Fisher Scientific, Bio-Rad Laboratories, Abcam Plc, Merck KGaA, BioLifeSolutions Inc., HiMedia Laboratories, AMSBIO, BIOGENUIX MEDSYSTEM PVT.LTD.
Autoimmunity Reagents Market Technology Innovations, Trends and Demand 2022 to 2027| EUROIMMUN, HUMAN, Bio-Rad Laboratories
05:50am, Wednesday, 22'nd Dec 2021 OpenPR
This report studies the Global Autoimmunity Reagents Market with many aspects of the industry like the market size, market status, market trends and forecast, the report also provides brief information of the competitors and the specific growth opportunities with key
Bio-Rad Laboratories (NYSE:BIO.B) Hits New 1-Year High at $722.91
12:22am, Wednesday, 22'nd Dec 2021 Dakota Financial News
Bio-Rad Laboratories, Inc. (NYSE:BIO.B)s stock price reached a new 52-week high during trading on Tuesday . The company traded as high as $722.91 and last traded at $722.91, with a volume of 6 shares. The stock had previously closed at $722.91. The business has a fifty day simple moving average of $744.09 and a 200 []
TTC Oncology Launches Equity Crowdfunding Campaign on WeFunder to Support Funding of Phase 2 Clinical Trials for Breast Cancer With $100,000 Initial Investment
08:19pm, Monday, 20'th Dec 2021 Kwhen FinanceCritical Contrast: Bio-Rad Laboratories (NYSE:BIO.B) and IsoPlexis (NASDAQ:ISO)
06:12am, Monday, 20'th Dec 2021 ETF Daily News
Bio-Rad Laboratories (NYSE:BIO.B) and IsoPlexis (NASDAQ:ISO) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, earnings, valuation, institutional ownership, risk, profitability and analyst recommendations. Earnings and Valuation This table compares Bio-Rad Laboratories and IsoPlexis top-line revenue, earnings per share and valuation. [] The post Critical Contrast: Bio-Rad Laboratories (NYSE:BIO.B) and IsoPlexis (NASDAQ:ISO) appeared first on ETF Daily News .
This Infertility Testing And Treatment market report analyzed the market conditions of key region of the world including product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. The report introduced the new project SWOT analysis,
ASYMmetric ETFs Trust Buys Coterra Energy Inc, Baxter International Inc, Newmont Corp, Sells ...
03:38pm, Friday, 17'th Dec 2021 GuruFocus
Related Stocks: CTRA , NEM , DLR , AEP , CTXS , DLTR , BAX , NOW , OGN , BIO , CBOE ,
Bio-Rad Laboratories (NYSE:BIO.B) Hits New 1-Year High at $750.16
02:42pm, Friday, 17'th Dec 2021 Transcript Daily
Bio-Rad Laboratories, Inc. (NYSE:BIO.B) reached a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $750.16 and last traded at $750.16, with a volume of 8 shares traded. The stock had previously closed at $750.16. The firm has a market cap of $22.44 billion, a price-to-earnings ratio of 3.40 […]
Blair Norfolk Purchases 174,600 Shares of Biome Australia Ltd (ASX:BIO) Stock
12:44pm, Friday, 17'th Dec 2021 Transcript Daily
Biome Australia Ltd (ASX:BIO) insider Blair Norfolk acquired 174,600 shares of the companys stock in a transaction dated Friday, December 10th. The stock was bought at an average cost of A$0.10 ($0.07) per share, for a total transaction of A$17,634.60 ($12,596.14). About Biome Australia Bio-Rad Laboratories, Inc is a global leader in developing, manufacturing, and []
Franklin Custodian Funds Buys Repligen Corp, DoorDash Inc, Intellia Therapeutics Inc, Sells ...
10:38pm, Thursday, 16'th Dec 2021 GuruFocus
Related Stocks: RGEN , DASH , NTLA , ABNB , MNDY , BIO , CRL , S , S , 0A8V , FRSH , FRSH , PINS , WIX , CSGP , NARI , ZEN , GH , 7974 , UBER , RNG , QTWO , 03690 , EQIX ,
Bio-Rad Laboratories (NYSE:BIO.B) Reaches New 1-Year High at $750.16
12:18am, Thursday, 16'th Dec 2021 Dakota Financial News
Bio-Rad Laboratories, Inc. (NYSE:BIO.B)s share price hit a new 52-week high during trading on Wednesday . The company traded as high as $750.16 and last traded at $750.16, with a volume of 8 shares traded. The stock had previously closed at $750.16. The firm has a market capitalization of $22.44 billion, a P/E ratio of []
Paper Diagnostics - Market to See Huge Growth by 2027 | Abbott, Bio-Rad Laboratories, Siemens Healthcare, Abcam
05:29pm, Tuesday, 14'th Dec 2021 OpenPR
According to new research study, Global Paper Diagnostics Market Research Report 2027 thinks about key breakdowns in the industry with insights about the market drivers and market restrictions. The report illuminates accumulating an all encompassing rundown of factual investigation for
Automated and Rapid Microbiological Tests Market Soaring CAGR +9% by 2021-2027|| Becton Dickinson and Company, Bio-Rad Laboratories, Inc.
11:27am, Tuesday, 14'th Dec 2021 OpenPR
The rapid microbial methods are also known as another microbiological method, are the technologies that allow the user to get microbiology test results faster likened to traditional culture-plate approaches. Miller Faster means in a substance of hours, as opposed to
At 8.3% CAGR, PCR Market Size [2021-2028] To Hit USD 8.14 Billion - Fortune Business Insights
08:42am, Tuesday, 14'th Dec 2021 Intrado Digital Media
Key Companies in PCR Market are Agilent Technologies, Inc., Qiagen, Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., Sysmex Inostic, Abbott, Thermo Fischer Scientific Inc., Eppendorf AG, Other players Key Companies in PCR Market are Agilent Technologies, Inc., Qiagen, Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., Sysmex Inostic, Abbott, Thermo Fischer Scientific Inc., Eppendorf AG, Other players
Sign In
Buy BIO